{"id":"W3166324988","doi":"10.1016/j.cllc.2021.05.009","title":"Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)","year":2021,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre","funders":"Genentech; Daiichi-Sankyo; Merck KGaA; Moffitt Cancer Center; Takeda Pharmaceuticals U.S.A.; Spectrum Pharmaceuticals; Sanofi; Novartis; Merck; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Roche; Astellas Pharma US; Boehringer Ingelheim; Amgen; Pfizer","keywords":"Durvalumab; Medicine; Chemoradiotherapy; Stage (stratigraphy); Lung cancer; Oncology; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004492147,0.0003946904,0.0009814274,0.00009517416,0.00007594133,0.0000679329,0.000197141,0.0002906533,0.005227425],"category_scores_gemma":[0.00003388811,0.0003157662,0.0003028083,0.0005992274,0.0002209747,0.0001307478,0.00005948053,0.0007062276,0.000005948883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007874605,"about_ca_system_score_gemma":0.001586292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009950176,"about_ca_topic_score_gemma":0.002424817,"domain_scores_codex":[0.9967985,0.0001435867,0.0009645513,0.0008911364,0.000529075,0.0006732229],"domain_scores_gemma":[0.9982782,0.0001810412,0.0002717517,0.0006329213,0.0003516051,0.0002844668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00938936,0.001041082,0.9519863,0.0005732392,0.0005093963,0.0001386958,0.0004249018,0.00002458332,0.0004606717,0.000002240373,0.007668559,0.02778095],"study_design_scores_gemma":[0.05247441,0.001175423,0.8695996,0.002299591,0.0004634723,0.000004095433,0.0002345683,0.001386343,0.002793924,0.000001964702,0.068721,0.0008455887],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9672751,0.02659239,0.0001187728,0.00104744,0.001694346,0.001378116,0.0001720657,0.00005001611,0.001671783],"genre_scores_gemma":[0.9726806,0.008925749,0.0001980272,0.002674429,0.0005894432,0.0007327486,0.00008162842,0.000102152,0.01401517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08238671,"threshold_uncertainty_score":0.9999294,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01887738721131567,"score_gpt":0.3471904455025281,"score_spread":0.3283130582912124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}